• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.

作者信息

Hawksbee Luke, McKee Martin, King Lawrence

机构信息

Department of Sociology, University of Cambridge, Cambridge, UK

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

BMJ. 2022 Jan 31;376:e067367. doi: 10.1136/bmj-2021-067367.

DOI:10.1136/bmj-2021-067367
PMID:35101900
Abstract
摘要

相似文献

1
Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.在考虑豁免新冠病毒知识产权时,无需担心制药行业的利润。
BMJ. 2022 Jan 31;376:e067367. doi: 10.1136/bmj-2021-067367.
2
Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.在考虑豁免新冠疫情相关知识产权时,不要担心制药行业的利润。
BMJ. 2022 Feb 23;376:o482. doi: 10.1136/bmj.o482.
3
Profiteering from vaccine inequity: a crime against humanity?从疫苗不公平中牟取暴利:反人类罪?
BMJ. 2021 Aug 16;374:n2027. doi: 10.1136/bmj.n2027.
4
Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem.对提议的知识产权豁免作为解决新冠疫苗短缺问题机制的评估。
J Epidemiol Community Health. 2022 Apr;76(4):317-318. doi: 10.1136/jech-2021-218409. Epub 2022 Feb 9.
5
Profits First, Health Second: The Pharmaceutical Industry and the Global South Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap".利润优先,健康其次:制药行业与全球南方国家对“更多痛苦,更多收获!新冠疫苗的供应与制药行业在扩大获取差距方面的作用”的评论。
Int J Health Policy Manag. 2024;13:8471. doi: 10.34172/ijhpm.2024.8471. Epub 2024 May 18.
6
A patent waiver on COVID vaccines is right and fair.新冠疫苗专利豁免是正确且公平的。
Nature. 2021 May;593(7860):478. doi: 10.1038/d41586-021-01242-1.
7
It's time to consider a patent reprieve for COVID vaccines.是时候考虑暂缓新冠疫苗的专利了。
Nature. 2021 Apr;592(7852):7. doi: 10.1038/d41586-021-00863-w.
8
New WTO leader faces COVID-19 challenges.世贸组织新领导人面临新冠疫情挑战。
Lancet. 2021 Feb 27;397(10276):782. doi: 10.1016/S0140-6736(21)00507-9.
9
Is there light at the end of the Covid-19 tunnel?新冠疫情的隧道尽头会有曙光吗?
Rev Med Virol. 2021 May;31(3):e2173. doi: 10.1002/rmv.2173. Epub 2020 Oct 1.
10
Pool patents to get COVID vaccines and drugs to all.集中专利,让所有人都能获得新冠疫苗和药物。
Nature. 2021 Mar;591(7851):529. doi: 10.1038/d41586-021-00759-9.

引用本文的文献

1
Decolonising vaccine production: Unpacking Ghanaians' support for made-in-Africa vaccines.使疫苗生产去殖民化:剖析加纳人对非洲制造疫苗的支持。
Vaccine X. 2023 Mar 17;14:100283. doi: 10.1016/j.jvacx.2023.100283. eCollection 2023 Aug.
2
Changes in industry marketing payments to physicians during the covid-19 pandemic: quasi experimental, difference-in-difference study.新冠疫情期间行业向医生支付营销费用的变化:准实验性差异研究
BMJ Med. 2022 Sep 6;1(1):e000219. doi: 10.1136/bmjmed-2022-000219. eCollection 2022.